C12Q 2521/537
Protease
C12Q2521/537 (Protease) appears on 10 US grants and 22 published applications in this corpus.
Search patents in C12Q- Granted patents
- 10
- Published applications
- 22
- Assignees
- 15
- Inventors
- 50
- Latest grant
- 21 May 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 2 |
| 2013 | 0 | 0 |
| 2014 | 1 | 1 |
| 2015 | 1 | 0 |
| 2016 | 0 | 3 |
| 2017 | 1 | 0 |
| 2018 | 1 | 2 |
| 2019 | 0 | 2 |
| 2020 | 2 | 4 |
| 2021 | 0 | 2 |
| 2022 | 2 | 2 |
| 2023 | 1 | 1 |
| 2024 | 1 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method of producing an immunoligand/payload conjugate21 May 2024US 11,986,535 B2Nbe-Therapeutics AG
- Methods and compositions for extracting nucleic acids using ferric oxide particles13 Jun 2023US 11,674,133 B2Becton, Dickinson and Company
- Method of producing an immunoligand/payload conjugate21 Jun 2022US 11,364,301 B2Nbe-Therapeutics AG
- Method and apparatus for simultaneous targeted sequencing of DNA, RNA and protein21 Jun 2022US 11,365,441 B2Mission Bio, Inc.
- Method of producing an immunoligand/payload conjugate15 Dec 2020US 10,864,277 B2Nbe-Therapeutics AG
- Method and apparatus for simultaneous targeted sequencing of dna, rna and protein5 Feb 2026US 2026/0035739 A1Mission Bio, Inc.
- Method for determining protease activity in a biological sample21 Nov 2024US 2024/0384323 A1CytomX Therapeutics, Inc.
- Method for measuring the protease activity of c3 and c5 convertase of the alternative complement pathway24 Aug 2023US 2023/0265481 A1Alexion Pharmaceuticals, Inc.
- Method of producing an immunoligand/payload conjugate1 Dec 2022US 2022/0378927 A1Nbe-Therapeutics AG
- Method and apparatus for simultaneous targeted sequencing of dna, rna and protein20 Oct 2022US 2022/0333170 A1Mission Bio, Inc.
Most cited
By later US patents
- Non-invasive determination of fetal inheritance of parental haplotypes at the genome-wide scale21US 8,877,442 B2The Board of Trustees of the Leland Stanford Junior University · 2014
- Method of producing an immunoligand/payload conjugate16US 9,872,923 B2Nbe-Therapeutics AG · 2018
- Method of producing an immunoligand/payload conjugate9US 10,864,277 B2Nbe-Therapeutics AG · 2020
- Method of producing an immunoligand/payload conjugate4US 11,364,301 B2Nbe-Therapeutics AG · 2022
- Method and apparatus for simultaneous targeted sequencing of DNA, RNA and protein1US 11,365,441 B2Mission Bio, Inc. · 2022